January 31, 2017
Teva launches two asthma products in 2017 to compete with GSK
Teva’s two asthma treatments for patients older than 12 has been approved by the US Food and Drug Administration (FDA).
Pharmaceuticals, Biotechnology and Life Sciences
Teva’s two asthma treatments for patients older than 12 has been approved by the US Food and Drug Administration (FDA).
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
GSK has announced on Tuesday that it intends to appoint Deloitte LLP (“Deloitte”) as its auditor with effect from the…